Retinal Degenerative Diseases

This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathol...

Full description

Bibliographic Details
Other Authors: LaVail, Matthew M. (Editor), Ash, John (Editor), Anderson, Robert E. (Editor), Hollyfield, Joe G. (Editor)
Format: eBook
Language:English
Published: New York, NY Springer New York 2012, 2012
Edition:1st ed. 2012
Series:Advances in Experimental Medicine and Biology
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 01821nmm a2200349 u 4500
001 EB000363684
003 EBX01000000000000000216736
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9781461406310 
100 1 |a LaVail, Matthew M.  |e [editor] 
245 0 0 |a Retinal Degenerative Diseases  |h Elektronische Ressource  |c edited by Matthew M. LaVail, John Ash, Robert E. Anderson, Joe G. Hollyfield, Christian Grimm 
250 |a 1st ed. 2012 
260 |a New York, NY  |b Springer New York  |c 2012, 2012 
300 |a LXIV, 864 p. 196 illus., 88 illus. in color  |b online resource 
653 |a Geriatrics 
653 |a Clinical Genetics 
653 |a Immunology 
653 |a Ophthalmology 
653 |a Medical genetics 
700 1 |a Ash, John  |e [editor] 
700 1 |a Anderson, Robert E.  |e [editor] 
700 1 |a Hollyfield, Joe G.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Advances in Experimental Medicine and Biology 
028 5 0 |a 10.1007/978-1-4614-0631-0 
856 4 0 |u https://doi.org/10.1007/978-1-4614-0631-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.079 
082 0 |a 571.96 
520 |a This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy